Peraso SEC Filings

Peraso Inc. disclosed the detailed schedule of outstanding equity instruments that could convert into common stock, listing option, warrant, restricted stock unit, and reserve quantities. Key items include 837,380 shares held in abeyance, 1,333,794 shares from outstanding stock options (weighted average exercise price $3.38), a 213,438 share reserve under its 2019 Stock Incentive Plan, and multiple tranches of warrants across 2022–2025 with exercise prices ranging from $1.25 to $40.00. The filing shows 952,380 Series E warrants dated September 12, 2025 at an exercise price of $1.25 and 66,667 placement agent warrants at $1.475. Aggregating the listed items yields approximately 11.5 million shares of common stock potentially issuable upon exercise or conversion of the instruments disclosed.

Peraso Inc. (PRSO) filed a Form D reporting a completed Regulation D offering totaling $1,288,809. The filing states the offering involved equity and related warrants: 952,380 shares issuable upon exercise of Series E warrants at $1.25 per share and 66,667 shares issuable upon exercise of placement agent warrants at $1.475 per share.

The offering was conducted under Rule 506(b) with a reported first sale date of 2025-09-11 and shows a single investor participated. Ladenburg Thalmann & Co. Inc. is listed as the broker-dealer, sales commissions are reported as $244,477 (estimate), and the issuer indicates $0 of the proceeds were used to pay executive officers, directors or promoters.

Peraso Inc. received a Schedule 13G/A in which Iroquois Capital Management, LLC, Richard Abbe and Kimberly Page report warrants and beneficial ownership rights for Peraso common stock. The filing discloses reported securities to purchase a combined 1,428,570 shares, with reported allocations of 371,424 shares to Iroquois, 1,057,146 shares attributable solely to Mr. Abbe and 371,424 shares attributable to Ms. Page, and shows shared interests of 371,424 shares among the parties.

The filing states the percentages were calculated using 5,027,173 shares outstanding and reports 9.99% for Mr. Abbe and 6.88% for Iroquois and Ms. Page. The reported warrants are subject to a 9.99% blocker, and the cover-page counts reflect shares issuable upon full exercise without applying the blocker, meaning the actual exercisable ownership will be lower. The filers certify these securities were not acquired to change or influence control of the issuer.

Peraso Inc. reported total net revenue of $2.22 million for the quarter and $6.09 million for the six months ended June 30, 2025, with product sales shifting away from discontinued memory ICs toward mmWave ICs and antenna modules. The company recorded a net loss of $1.83 million for the quarter and $2.30 million for the six months, and had cash and cash equivalents of $1.76 million and an accumulated deficit of approximately $179.4 million as of June 30, 2025.

The company completed final end-of-life shipments for its memory ICs in March 2025, reported improved six-month gross profit driven by mmWave product sales, reduced R&D and SG&A costs, and raised proceeds from at-the-market sales. The board has launched a strategic review after receiving an unsolicited, non-binding proposal from Mobix Labs and is pursuing additional financings. Management and the auditor have expressed substantial doubt about the company’s ability to continue as a going concern without additional capital.

Peraso Inc. (PRSO) Chief Technology Officer Alex Tomkins was granted a stock option to purchase 25,000 shares on August 7, 2025 with an exercise price of $0.8399. The option is reported as direct beneficial ownership of 25,000 derivative securities and the filing shows the option price reported as $0.00 in the form's table.

The option vests as to 1/36th of the shares on each monthly anniversary following August 7, 2025. The Form 4 was signed by James Sullivan by power of attorney on August 11, 2025. The filing does not disclose total shares outstanding or the percentage this grant represents, so materiality relative to the company's equity cannot be determined from this Form 4 alone.